Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

NCT03320330 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

NETWORK

Sponsor class

Conditions

Recurrent Malignant Solid Neoplasm
Recurrent Osteosarcoma
Refractory Malignant Solid Neoplasm
Refractory Osteosarcoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pepinemab
OTHER: Pharmacological Study

Sponsor

Children's Oncology Group

Collaborators

[object Object]